AML stem-like cells that are most likely to cause relapse may readily activate NFκB-driven gene expression due to their remodeled chromatin, exclusively overcome G1 arrest of the cell cycle, and express antiapoptotic factors, such as BCL2 [250,251,252]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.